Gaithersburg, Maryland and SEOUL, Korea, – Seegene Inc., (096530.KQ), a leading developer of multiplex molecular diagnostic technologies and tests, today announced the development of a new molecular technology that for the first time allows high multiplexing and multiple quantification from a single sample in a single tube. Seegene’s real-time multiplex PCR technology allows the simultaneous […]
SEATTLE, Wash. – NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostics, today announced the appointment of Bruce J. Seeley as Senior Vice President & General Manager, Diagnostics. In this role, Mr. Seeley will have responsibility for providing strategic direction and commercial leadership for NanoString’s […]
Agilent Technologies Inc. (NYSE: A) today launched additional Agilent SureFISH probes, creating the largest offering of oligonucleotide-based fluorescent in situ hybridization (FISH) assays on the market. Over 425 probes are now available from Agilent, including centromere probes for all 24 chromosomes, and 35 telomere probes. Agilent SureFISH probes are designed for specific, nonrepetitive regions of […]
SAN DIEGO, — Trovagene, Inc. (Nasdaq: TROVD), a developer of trans-renal molecular diagnostics, announced the pricing of an underwritten public offering of 1,150,000 units at an offering price of $8.00 per unit, with each unit consisting of two shares of common stock and one warrant to purchase one share of common stock. The units will […]
Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that Chief Executive Officer and President Vincent A. Forlenza will assume additional responsibility as Chairman of the Board, effective July 1, 2012, following his appointment by the Board of Directors. Mr. Forlenza will succeed Edward J. Ludwig, […]
Omaha, Neb.- Transgenomic, Inc. (OTC/BB: TBIO) today announced it has entered into an agreement with Gene Logic, Inc., an Ocimum Biosolutions Company, to acquire its biorepository assets for $250,000 in cash. The biorepository contains thousands of human biological samples that can be used to validate diagnostic assays developed by Transgenomic. Transgenomic will use the samples […]
Cepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
SUNNYVALE, Calif., — Cepheid (NASDAQ: CPHD) today announced that the U.S. Food & Drug Administration (FDA) has cleared its GeneXpert Infinity-80 System, a high-throughput automated molecular system designed to deliver around-the-clock results for a wide variety of clinical testing applications. The GeneXpert Infinity-80 has been initially cleared in conjunction with Cepheid’s Xpert Flu test. “With […]
SUNNYVALE, Calif.,– Cepheid (NASDAQ: CPHD) today announced that both Xpert CT/NG and Xpert CT have received CE marking, with shipments expected to begin immediately. Running on Cepheid’s GeneXpert System, the products are qualitative in vitro molecular diagnostic tests for the rapid detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). With results in […]
MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its division for research and diagnostic antibodies, AbD Serotec, will launch a series of novel anti-drug antibodies (ADAs) to strengthen its position as a leading provider of diagnostic reagents. Starting with the recent launch of fully human, recombinant antibodies binding Rituximab (Rituxan®) and Trastuzumab […]
Lucigen Corporation announced today that it has recently been awarded its largest SBIR Phase II grant to date to fund research and development of a point of care diagnostic test for influenza. The National Institutes of Health has awarded Lucigen a total of $2.8M in a Small Business Innovation Research grant to be used to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
